{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:22:52Z","timestamp":1793694172453,"version":"4.5.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.chembiol.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T21:43:27Z","timestamp":1615326207000},"page":"711-721.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-8335","authenticated-orcid":false,"given":"Luciana S.","family":"Paradela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-1683","authenticated-orcid":false,"given":"Sandra","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3868-6752","authenticated-orcid":false,"given":"Giulia","family":"Chemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-6486","authenticated-orcid":false,"given":"Victoriano","family":"Corpas-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-7380","authenticated-orcid":false,"given":"Eoin","family":"Moynihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9780-263X","authenticated-orcid":false,"given":"Davide","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia S.","family":"G\u00fcther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5134-0329","authenticated-orcid":false,"given":"Alan H.","family":"Fairlamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1321-8714","authenticated-orcid":false,"given":"Michael A.J.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-7423","authenticated-orcid":false,"given":"Fabio","family":"Zuccotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Wyllie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2021.02.008_bib1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/jac\/dkx516","article-title":"What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment","volume":"73","author":"Aldasoro","year":"2018","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.chembiol.2021.02.008_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2021.02.008_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.actatropica.2011.05.001","article-title":"The pharmacological inhibition of sterol biosynthesis in Leishmania is counteracted by enhancement of LDL endocytosis","volume":"119","author":"Andrade-Neto","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.chembiol.2021.02.008_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-4362.1997.00021.x","article-title":"Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study","volume":"36","author":"Bahamdan","year":"1997","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.chembiol.2021.02.008_bib5","doi-asserted-by":"crossref","first-page":"e0006925","DOI":"10.1371\/journal.pntd.0006925","article-title":"The elimination of human African trypanosomiasis is in sight: report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis","volume":"12","author":"Barrett","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chembiol.2021.02.008_bib6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4269\/ajtmh.1981.30.566","article-title":"Activity of imidazoles against Leishmania tropica in human macrophage cultures","volume":"30","author":"Berman","year":"1981","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chembiol.2021.02.008_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2307\/3282158","article-title":"In\u00a0vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents","volume":"73","author":"Berman","year":"1987","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.chembiol.2021.02.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-6851(84)90039-2","article-title":"Effects of ketoconazole on growth and sterol biosynthesis of Leishmania mexicana promastigotes in culture","volume":"12","author":"Berman","year":"1984","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.chembiol.2021.02.008_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1432-1033.1996.0410r.x","article-title":"Synthetic phospho-oligosaccharide fragments of lipophosphoglycan as acceptors for Leishmania major alpha-D-mannosylphosphate transferase","volume":"242","author":"Brown","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.chembiol.2021.02.008_bib10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1128\/AAC.45.4.1210-1215.2001","article-title":"Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors","volume":"45","author":"Buckner","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2021.02.008_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/bioinformatics\/btr703","article-title":"Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data","volume":"28","author":"Carver","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2021.02.008_bib12","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1074\/mcp.TIR119.001481","article-title":"Nonparametric analysis of thermal proteome profiles reveals novel drug-binding proteins","volume":"18","author":"Childs","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.chembiol.2021.02.008_bib13","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1073\/pnas.85.18.6753","article-title":"Receptors for the host low density lipoproteins on the hemoflagellate Trypanosoma brucei: purification and involvement in the growth of the parasite","volume":"85","author":"Coppens","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chembiol.2021.02.008_bib14","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1074\/jbc.270.11.5736","article-title":"Host plasma low density lipoprotein particles as an essential source of lipids for the bloodstream forms of Trypanosoma brucei","volume":"270","author":"Coppens","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2021.02.008_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/acsinfecdis.8b00226","article-title":"Pharmacological validation of N-Myristoyltransferase as a drug target in leishmania donovani","volume":"5","author":"Corpas-Lopez","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.chembiol.2021.02.008_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.chembiol.2021.02.008_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.exppara.2012.02.014","article-title":"LDL uptake by Leishmania amazonensis: involvement of membrane lipid microdomains","volume":"130","author":"De Cicco","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.chembiol.2021.02.008_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S003118201300142X","article-title":"Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections","volume":"141","author":"Don","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.chembiol.2021.02.008_bib19","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nprot.2015.101","article-title":"Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry","volume":"10","author":"Franken","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2021.02.008_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nprot.2015.005","article-title":"Genome-scale RNAi screens for high-throughput phenotyping in bloodstream-form African trypanosomes","volume":"10","author":"Glover","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2021.02.008_bib21","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1016\/0006-2952(85)90250-3","article-title":"Effect of the allylamine antifungal drug SF 86-327 on the growth and sterol synthesis of Leishmania mexicana mexicana promastigotes","volume":"34","author":"Goad","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chembiol.2021.02.008_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-6851(03)00142-7","article-title":"An in\u00a0vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans","volume":"130","author":"Goyard","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"issue":"Pt 1","key":"10.1016\/j.chembiol.2021.02.008_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/bj3080031","article-title":"Effects of an azasterol inhibitor of sterol 24-transmethylation on sterol biosynthesis and growth of Leishmania donovani promastigotes","volume":"308","author":"Haughan","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.chembiol.2021.02.008_bib24","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1021\/jm034126t","article-title":"Oxidosqualene cyclase inhibitors as antimicrobial agents","volume":"46","author":"Hinshaw","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2021.02.008_bib25","doi-asserted-by":"crossref","DOI":"10.1086\/656917","article-title":"Tolerance and safety of nifurtimox in patients with chronic chagas disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.chembiol.2021.02.008_bib26","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2021.02.008_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2021.02.008_bib28","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1021\/jm0211218","article-title":"Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene-hopene cyclase","volume":"46","author":"Lenhart","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2021.02.008_bib29","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2021.02.008_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-014-2996-5","article-title":"Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071","volume":"146","author":"Liang","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.chembiol.2021.02.008_bib31","first-page":"3223","article-title":"Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells","volume":"9","author":"Liang","year":"2016","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.chembiol.2021.02.008_bib32","doi-asserted-by":"crossref","first-page":"9054","DOI":"10.1038\/srep09054","article-title":"The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination","volume":"5","author":"Maione","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2021.02.008_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0022-2275(20)37643-4","article-title":"Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells","volume":"37","author":"Mark","year":"1996","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.chembiol.2021.02.008_bib34","doi-asserted-by":"crossref","first-page":"e0003588","DOI":"10.1371\/journal.pntd.0003588","article-title":"Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase","volume":"9","author":"McCall","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chembiol.2021.02.008_bib35","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/ci700018y","article-title":"New and original pKa prediction method using grid molecular interaction fields","volume":"47","author":"Milletti","year":"2007","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.chembiol.2021.02.008_bib36","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2021.02.008_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-2275(20)37449-6","article-title":"Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin","volume":"38","author":"Morand","year":"1997","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.chembiol.2021.02.008_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trstmh.2006.02.005","article-title":"Unresponsiveness to AmBisome in some Sudanese patients with kala-azar","volume":"101","author":"Mueller","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.chembiol.2021.02.008_bib40","doi-asserted-by":"crossref","first-page":"e0007381","DOI":"10.1371\/journal.pntd.0007381","article-title":"The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis","volume":"13","author":"Pelfrene","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chembiol.2021.02.008_bib41","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource","volume":"5","author":"Pe\u00f1a","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2021.02.008_bib42","doi-asserted-by":"crossref","first-page":"e22359","DOI":"10.1371\/journal.pone.0022359","article-title":"Trypanosoma cruzi epimastigotes are able to store and mobilize high amounts of cholesterol in reservosome lipid inclusions","volume":"6","author":"Pereira","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2021.02.008_bib43","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2021.02.008_bib44","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1073\/pnas.1820989116","article-title":"Target identification reveals lanosterol synthase as a vulnerability in glioma","volume":"116","author":"Phillips","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chembiol.2021.02.008_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0968-0004(94)90276-3","article-title":"A specific amino acid repeat in squalene and oxidosqualene cyclases","volume":"19","author":"Poralla","year":"1994","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.chembiol.2021.02.008_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2021.02.008_bib47","doi-asserted-by":"crossref","first-page":"e0004014","DOI":"10.1371\/journal.pntd.0004014","article-title":"Development of a fluorescence-based trypanosoma cruzi CYP51 inhibition assay for effective compound triaging in drug discovery programmes for chagas disease","volume":"9","author":"Riley","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chembiol.2021.02.008_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(02)00280-3","article-title":"Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa","volume":"126","author":"Roberts","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.chembiol.2021.02.008_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0968-0896(95)00177-8","article-title":"Design, synthesis and in\u00a0vitro evaluation of pyridinium ion based cyclase inhibitors and antifungal agents","volume":"4","author":"Rose","year":"1996","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.chembiol.2021.02.008_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis","volume":"89","author":"Saenz","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.chembiol.2021.02.008_bib51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1586\/14787210.4.2.177","article-title":"Miltefosine: oral treatment of leishmaniasis","volume":"4","author":"Soto","year":"2006","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.chembiol.2021.02.008_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature02993","article-title":"Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase","volume":"432","author":"Thoma","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2021.02.008_bib53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/acsinfecdis.9b00426","article-title":"The Q(i) site of cytochrome b is a promiscuous drug target in trypanosoma cruzi and leishmania donovani","volume":"6","author":"Wall","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.chembiol.2021.02.008_bib54","doi-asserted-by":"crossref","first-page":"e00235-18","DOI":"10.1128\/AAC.00235-18","article-title":"Antitrypanosomal 8-hydroxy-naphthyridines are chelators of divalent transition metals","volume":"62","author":"Wall","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2021.02.008_bib55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2958.2009.06761.x","article-title":"Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods","volume":"74","author":"Wyllie","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.chembiol.2021.02.008_bib56","doi-asserted-by":"crossref","first-page":"119re111","DOI":"10.1126\/scitranslmed.3003326","article-title":"The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis","volume":"4","author":"Wyllie","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chembiol.2021.02.008_bib57","doi-asserted-by":"crossref","first-page":"e1004427","DOI":"10.1371\/journal.ppat.1004427","article-title":"Sterol biosynthesis is required for heat resistance but not extracellular survival in leishmania","volume":"10","author":"Xu","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2021.02.008_bib58","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1371\/journal.pntd.0000488","article-title":"Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of M\u00e9decins Sans Fronti\u00e8res","volume":"3","author":"Yun","year":"2009","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945621000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945621000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:39:41Z","timestamp":1762526381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945621000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2451945621000933"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2021.02.008","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}